{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:13:59Z","timestamp":1790651639832,"version":"4.1.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bcp.2019.113692","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:42:46Z","timestamp":1573040566000},"page":"113692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Mouse models in hematopoietic stem cell gene therapy and genome editing"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2842-4820","authenticated-orcid":false,"given":"Stefan","family":"Radtke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.113692_b0005","article-title":"Humanized mouse models: application to human diseases","author":"Ito","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.113692_b0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu. Rev. Pathol."},{"issue":"4873","key":"10.1016\/j.bcp.2019.113692_b0020","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.2971269","article-title":"The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function","volume":"241","author":"McCune","year":"1988","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"Shultz","year":"1995","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/hmg\/4.2.163","article-title":"Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols","volume":"4","author":"Larochelle","year":"1995","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2019.113692_b0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"5402","key":"10.1016\/j.bcp.2019.113692_b0040","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.283.5402.682","article-title":"Transduction of human CD34+ cells that mediate long-term engraftment of NOD\/SCID mice by HIV vectors","volume":"283","author":"Miyoshi","year":"1999","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0045","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1006\/mthe.2000.0077","article-title":"Transduction of human CD34+ CD38\u2212 bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors","volume":"1","author":"Guenechea","year":"2000","journal-title":"Mol. Therapy"},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.exphem.2016.02.011","article-title":"The frequency of multipotent CD133(+)CD45RA(-)CD34(+) hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources","volume":"44","author":"Radtke","year":"2016","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcp.2019.113692_b0055","article-title":"Distinct routes of lineage development reshape the human blood hierarchy across ontogeny","author":"Notta","year":"2015","journal-title":"Science"},{"issue":"6203","key":"10.1016\/j.bcp.2019.113692_b0060","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.113692_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2017.05.023","article-title":"Improving gene therapy efficiency through the enrichment of human hematopoietic stem cells","author":"Masiuk","year":"2017","journal-title":"Mol. Therapy"},{"issue":"4","key":"10.1016\/j.bcp.2019.113692_b0070","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.stemcr.2017.02.010","article-title":"Efficient ex vivo engineering and expansion of highly purified human hematopoietic stem and progenitor cell populations for gene therapy","volume":"8","author":"Zonari","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.bcp.2019.113692_b0075","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41375-018-0277-8","article-title":"Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR\/Cas9-deletion of CD33 exon 2","volume":"33","author":"Humbert","year":"2019","journal-title":"Leukemia"},{"issue":"7655","key":"10.1016\/j.bcp.2019.113692_b0080","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature22370","article-title":"Haematopoietic stem and progenitor cells from human pluripotent stem cells","volume":"545","author":"Sugimura","year":"2017","journal-title":"Nature"},{"issue":"7655","key":"10.1016\/j.bcp.2019.113692_b0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature22326","article-title":"Conversion of adult endothelium to immunocompetent haematopoietic stem cells","volume":"545","author":"Lis","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2019.113692_b0090","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI79328","article-title":"Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells","volume":"125","author":"Gori","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bcp.2019.113692_b0095","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1073\/pnas.89.7.2804","article-title":"Isolation of a candidate human hematopoietic stem-cell population","volume":"89","author":"Baum","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.bcp.2019.113692_b0100","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1073\/pnas.94.10.5320","article-title":"Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice","volume":"94","author":"Bhatia","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","article-title":"Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood","volume":"1","author":"Majeti","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"6039","key":"10.1016\/j.bcp.2019.113692_b0110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1201219","article-title":"Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment","volume":"333","author":"Notta","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.113692_b0115","first-page":"16007","article-title":"Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS","volume":"3","author":"Peterson","year":"2016","journal-title":"Mol. Therapy"},{"issue":"20","key":"10.1016\/j.bcp.2019.113692_b0120","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2015-09-672337","article-title":"Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates","volume":"127","author":"Peterson","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcp.2019.113692_b0125","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt.3408","article-title":"Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors","volume":"33","author":"Wang","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"7504","key":"10.1016\/j.bcp.2019.113692_b0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13420","article-title":"Targeted genome editing in human repopulating haematopoietic stem cells","volume":"510","author":"Genovese","year":"2014","journal-title":"Nature"},{"issue":"7573","key":"10.1016\/j.bcp.2019.113692_b0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage (Review)","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2019.113692_b0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nbt0315-217","article-title":"$1-million price tag set for Glybera gene therapy","volume":"33","author":"Morrison","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.bcp.2019.113692_b0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd3835-c1","article-title":"Regulatory evaluation of Glybera in Europe \u2013 two committees, one mission","volume":"12","author":"Melchiorri","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/15665232113136660005","article-title":"General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination (Review)","volume":"13","author":"Baldo","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bcp.2019.113692_b0155","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fimmu.2014.00350","article-title":"Cell-mediated immunity to AAV vectors, evolving concepts and potential solutions (Review)","volume":"5","author":"Basner-Tschakarjan","year":"2014","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.113692_b0160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2019.113692_b0165","doi-asserted-by":"crossref","unstructured":"S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C.S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J.I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L.E. Leiva, M. Wissler, C. Prinz, T.H. Rabbitts, F. Le Deist, A. Fischer, M. Cavazzana-Calvo, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [erratum appears in Science. 2003 Oct 24;302(5645):568], Science 302(5644) (2003) 415\u2013419.","DOI":"10.1126\/science.1088547"},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2019.113692_b0175","doi-asserted-by":"crossref","unstructured":"C.J. Braun, K. Boztug, A. Paruzynski, M. Witzel, A. Schwarzer, M. Rothe, U. Modlich, R. Beier, G. Gohring, D. Steinemann, R. Fronza, C.R. Ball, R. Haemmerle, S. Naundorf, K. Kuhlcke, M. Rose, C. Fraser, L. Mathias, R. Ferrari, M.R. Abboud, W. Al-Herz, I. Kondratenko, L. Marodi, H. Glimm, B. Schlegelberger, A. Schambach, M.H. Albert, M. Schmidt, C. von Kalle, C. Klein, Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity, Science Translational Medicine 6(227) (2014) 227ra33.","DOI":"10.1126\/scitranslmed.3007280"},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0180","doi-asserted-by":"crossref","DOI":"10.4161\/21675511.2014.947749","article-title":"Gene therapy for Wiskott-Aldrich Syndrome-Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis","volume":"2","author":"Braun","year":"2014","journal-title":"Rare Diseases"},{"issue":"10","key":"10.1016\/j.bcp.2019.113692_b0185","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.ymthe.2018.08.025","article-title":"Sorting out the best: enriching hematopoietic stem cells for gene therapy and editing","volume":"26","author":"Radtke","year":"2018","journal-title":"Mol. Therapy"},{"issue":"9","key":"10.1016\/j.bcp.2019.113692_b0190","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ymthe.2017.05.023","article-title":"Improving gene therapy efficiency through the enrichment of human hematopoietic stem cells","volume":"25","author":"Masiuk","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bmt.1703792","article-title":"Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells","volume":"31","author":"Gordon","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bcp.2019.113692_b0200","doi-asserted-by":"crossref","unstructured":"S. Radtke, J.E. Adair, M.A. Giese, Y.Y. Chan, Z.K. Norgaard, M. Enstrom, K.G. Haworth, L.E. Schefter, H.P. Kiem, A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates, Sci. Transl. Med. 9(414) (2017) [Epub ahead of print; doi: 10.1126\/scitranslmed.aan1145].","DOI":"10.1126\/scitranslmed.aan1145"},{"key":"10.1016\/j.bcp.2019.113692_b0205","doi-asserted-by":"crossref","unstructured":"S. Radtke, Y.Y. Chan, T.R. Sippel, H.P. Kiem, A. Rongvaux, MISTRG mice support engraftment and assessment of nonhuman primate hematopoietic stem and progenitor cells, Exp. Hematol. 70 (2019) 31-41 e1.","DOI":"10.1016\/j.exphem.2018.12.003"},{"issue":"12","key":"10.1016\/j.bcp.2019.113692_b0210","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1182\/blood.V91.12.4489","article-title":"Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma","volume":"91","author":"Tricot","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bcp.2019.113692_b0215","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0301-472X(00)00169-7","article-title":"Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution","volume":"28","author":"Michallet","year":"2000","journal-title":"Exp. Hematol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113692_b0220","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1083-8791(00)70008-5","article-title":"Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer","volume":"6","author":"Negrin","year":"2000","journal-title":"Biol. Blood Marrow Transplantation"},{"issue":"12","key":"10.1016\/j.bcp.2019.113692_b0225","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/bbmt.2001.v7.pm11787531","article-title":"Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma","volume":"7","author":"Vose","year":"2001","journal-title":"Biol. Blood Marrow Transplantation"},{"issue":"503","key":"10.1016\/j.bcp.2019.113692_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3768","article-title":"Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates","volume":"11","author":"Humbert","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"414","key":"10.1016\/j.bcp.2019.113692_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan1145","article-title":"A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates","volume":"9","author":"Radtke","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.bcp.2019.113692_b0240","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1083\/jcb.201102131","article-title":"Cell cycle regulation in hematopoietic stem cells","volume":"195","author":"Pietras","year":"2011","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0245","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","article-title":"Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair","volume":"135","author":"Wilson","year":"2008","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0250","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stem.2010.06.014","article-title":"Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis","volume":"7","author":"Mohrin","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"360","key":"10.1016\/j.bcp.2019.113692_b0255","doi-asserted-by":"crossref","first-page":"360ra134","DOI":"10.1126\/scitranslmed.aaf9336","article-title":"Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells","volume":"8","author":"DeWitt","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2019.113692_b0260","first-page":"156","article-title":"UM171 enhances lentiviral gene transfer and recovery of primitive human hematopoietic cells","volume":"10","author":"Ngom","year":"2018","journal-title":"Mol. Therapy"},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ymthe.2017.09.025","article-title":"Prostaglandin E2 increases lentiviral vector transduction efficiency of adult human hematopoietic stem and progenitor cells","volume":"26","author":"Heffner","year":"2018","journal-title":"Mol. Therapy"},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/mt.2014.193","article-title":"Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells","volume":"23","author":"Petrillo","year":"2015","journal-title":"Mol. Therapy"},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.4021","article-title":"Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency","volume":"36","author":"Canny","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0280","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/scd.2016.0083","article-title":"Comparison of human hematopoietic reconstitution in different strains of immunodeficient mice","volume":"26","author":"Beyer","year":"2017","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0285","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2009.12.008","article-title":"Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation","volume":"135","author":"Brehm","year":"2010","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2019.113692_b0290","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.4049\/jimmunol.1103660","article-title":"Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD\/SCID\/IL2rgammaKO mice","volume":"188","author":"Tanaka","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113692_b0295","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.humimm.2012.01.006","article-title":"Monocytes derived from humanized neonatal NOD\/SCID\/IL2Rgamma(null) mice are phenotypically immature and exhibit functional impairments","volume":"73","author":"Gille","year":"2012","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2019.113692_b0300","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nm886","article-title":"Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells","volume":"9","author":"Mazurier","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20082013","article-title":"IL-15 trans-presentation promotes human NK cell development and differentiation in vivo","volume":"206","author":"Huntington","year":"2009","journal-title":"J. Exp. Med."},{"issue":"20","key":"10.1016\/j.bcp.2019.113692_b0310","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood-2010-02-270678","article-title":"Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence","volume":"116","author":"Strowig","year":"2010","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.bcp.2019.113692_b0315","doi-asserted-by":"crossref","DOI":"10.4161\/cc.26900","article-title":"New relationships of human hematopoietic lineages facilitate detection of multipotent hematopoietic stem and progenitor cells","volume":"12","author":"G\u00f6rgens","year":"2013","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.bcp.2019.113692_b0320","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt.2858","article-title":"Development and function of human innate immune cells in a humanized mouse model","volume":"32","author":"Rongvaux","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.bcp.2019.113692_b0325","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ni1527","article-title":"Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells","volume":"8","author":"Takenaka","year":"2007","journal-title":"Nat. Immunol."},{"issue":"51","key":"10.1016\/j.bcp.2019.113692_b0330","doi-asserted-by":"crossref","first-page":"21783","DOI":"10.1073\/pnas.0912274106","article-title":"Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.bcp.2019.113692_b0335","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/bloodadvances.2018023887","article-title":"Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models","volume":"3","author":"Sippel","year":"2019","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.bcp.2019.113692_b0340","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/leu.2010.158","article-title":"AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3","volume":"24","author":"Wunderlich","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0345","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.stem.2014.06.001","article-title":"Kit regulates HSC engraftment across the human-mouse species barrier","volume":"15","author":"Cosgun","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"13","key":"10.1016\/j.bcp.2019.113692_b0350","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1182\/blood-2003-01-0082","article-title":"Distinct hematopoietic stem\/progenitor cell populations are responsible for repopulating NOD\/SCID mice compared with nonhuman primates","volume":"102","author":"Horn","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcp.2019.113692_b0355","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hoc.2017.06.001","article-title":"In vivo hematopoietic stem cell transduction","volume":"31","author":"Richter","year":"2017","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0360","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI122836","article-title":"In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.bcp.2019.113692_b0365","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015","volume":"35","author":"Picard","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcp.2019.113692_b0370","doi-asserted-by":"crossref","unstructured":"A. Bousfiha, L. Jeddane, C. Picard, F. Ailal, H. Bobby Gaspar, W. Al-Herz, T. Chatila, Y.J. Crow, C. Cunningham-Rundles, A. Etzioni, J.L. Franco, S.M. Holland, C. Klein, T. Morio, H.D. Ochs, E. Oksenhendler, J. Puck, M.L.K. Tang, S.G. Tangye, T.R. Torgerson, J.L. Casanova, K.E. Sullivan, The 2017 IUIS Phenotypic classification for primary immunodeficiencies, J. Clin. Immunol. 38(1) (2018) 129\u2013143.","DOI":"10.1007\/s10875-017-0465-8"},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0375","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10875-017-0455-x","article-title":"Newborn screening for primary immunodeficiency diseases: history, current and future practice","volume":"38","author":"King","year":"2018","journal-title":"J. Clin. Immunol."},{"issue":"5235","key":"10.1016\/j.bcp.2019.113692_b0380","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bcp.2019.113692_b0385","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood.V80.5.1120.1120","article-title":"Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions","volume":"80","author":"Ferrari","year":"1992","journal-title":"Blood"},{"issue":"4999","key":"10.1016\/j.bcp.2019.113692_b0390","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1126\/science.1848369","article-title":"An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency","volume":"251","author":"Ferrari","year":"1991","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bcp.2019.113692_b0395","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1074\/jbc.273.9.5093","article-title":"Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency","volume":"273","author":"Blackburn","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0400","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4049\/jimmunol.173.2.1380","article-title":"A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice","volume":"173","author":"Young","year":"2004","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2019.113692_b0405","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2006-05-023507","article-title":"Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects","volume":"108","author":"Mortellaro","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bcp.2019.113692_b0410","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.bcp.2019.113692_b0415","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0420","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2009-10-250209","article-title":"A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0425","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","article-title":"Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration","volume":"24","author":"Montini","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113692_b0430","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0435","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2019.113692_b0440","doi-asserted-by":"crossref","unstructured":"G. Schiroli, S. Ferrari, A. Conway, A. Jacob, V. Capo, L. Albano, T. Plati, M.C. Castiello, F. Sanvito, A.R. Gennery, C. Bovolenta, R. Palchaudhuri, D.T. Scadden, M.C. Holmes, A. Villa, G. Sitia, A. Lombardo, P. Genovese, L. Naldini, Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1, Sci. Transl. Med. 9(411) (2017).","DOI":"10.1126\/scitranslmed.aan0820"},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0445","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2009.31","article-title":"Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models","volume":"17","author":"Marangoni","year":"2009","journal-title":"Mol. Therapy"},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0450","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/mt.2012.23","article-title":"Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome","volume":"21","author":"Scaramuzza","year":"2013","journal-title":"Mol. Therapy"},{"issue":"7","key":"10.1016\/j.bcp.2019.113692_b0455","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0301-472X(02)00838-X","article-title":"Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex","volume":"30","author":"Noll","year":"2002","journal-title":"Exp. Hematol."},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0460","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood.V100.6.2032","article-title":"In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice","volume":"100","author":"Rio","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bcp.2019.113692_b0465","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00109-012-0905-0","article-title":"Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities","volume":"90","author":"Adair","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"6","key":"10.1016\/j.bcp.2019.113692_b0470","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/mt.2008.67","article-title":"Rapid lentiviral transduction preserves the engraftment potential of Fanca(\u2212\/\u2212) hematopoietic stem cells","volume":"16","author":"Muller","year":"2008","journal-title":"Mol. Therapy"},{"issue":"13","key":"10.1016\/j.bcp.2019.113692_b0475","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2017-03-774174","article-title":"Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34(+) cells from Fanconi anemia patients","volume":"130","author":"Rio","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bcp.2019.113692_b0480","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41591-019-0550-z","article-title":"Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia","volume":"25","author":"Rio","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2019.113692_b0485","doi-asserted-by":"crossref","unstructured":"E.A. Dzierzak, T. Papayannopoulou, R.C. Mulligan, Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells, Nature 331(6151) (1988) 35\u201341.","DOI":"10.1038\/331035a0"},{"key":"10.1016\/j.bcp.2019.113692_b0490","doi-asserted-by":"crossref","unstructured":"D.Y. Tuan, W.B. Solomon, I.M. London, D.P. Lee, An erythroid-specific, developmental-stage-independent enhancer far upstream of the human \u201cbeta-like globin\u201d genes, Proc. Natl. Acad. Sci. U.S.A. 86(8) (1989) 2554\u20132558.","DOI":"10.1073\/pnas.86.8.2554"},{"issue":"7313","key":"10.1016\/j.bcp.2019.113692_b0495","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.113692_b0500","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-7428-3_3","article-title":"Mouse models of erythropoiesis and associated diseases","volume":"1698","author":"Parker","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"6791","key":"10.1016\/j.bcp.2019.113692_b0505","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35017565","article-title":"Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin","volume":"406","author":"May","year":"2000","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2019.113692_b0510","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1182\/blood-2002-10-3305","article-title":"A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer","volume":"101","author":"Rivella","year":"2003","journal-title":"Blood"},{"issue":"7629","key":"10.1016\/j.bcp.2019.113692_b0515","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.113692_b0520","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.omtn.2019.05.025","article-title":"In vivo outcome of homology-directed repair at the HBB gene in HSC using alternative donor template delivery methods","volume":"17","author":"Pattabhi","year":"2019","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.bcp.2019.113692_b0525","first-page":"137","article-title":"Long-term engraftment and fetal globin induction upon BCL11A gene editing in bone-marrow-derived CD34(+) hematopoietic stem and progenitor cells","volume":"4","author":"Chang","year":"2017","journal-title":"Mol. Therapy"},{"issue":"5","key":"10.1016\/j.bcp.2019.113692_b0530","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","article-title":"Highly efficient therapeutic gene editing of human hematopoietic stem cells","volume":"25","author":"Wu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2019.113692_b0535","first-page":"175","article-title":"TALEN-mediated gene editing of HBG in human hematopoietic stem cells leads to therapeutic fetal hemoglobin induction","volume":"12","author":"Lux","year":"2019","journal-title":"Mol. Therapy"},{"key":"10.1016\/j.bcp.2019.113692_b0540","doi-asserted-by":"crossref","unstructured":"G.M. Bendle, C. Linnemann, A.I. Hooijkaas, L. Bies, M.A. de Witte, A. Jorritsma, A.D. Kaiser, N. Pouw, R. Debets, E. Kieback, W. Uckert, J.Y. Song, J.B. Haanen, T.N. Schumacher, Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy, Nat Med 16(5) (2010) 565-70, 1p following 570.","DOI":"10.1038\/nm.2128"},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0545","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2249.2011.04462.x","article-title":"Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rgamma(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease","volume":"166","author":"Covassin","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2019.113692_b0550","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2015.05.002","article-title":"BLT humanized mice as a small animal model of HIV infection","volume":"13","author":"Karpel","year":"2015","journal-title":"Curr. Opin. Virol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113692_b0555","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2005-11-4388","article-title":"Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus\/liver and CD34+ cell transplantation","volume":"108","author":"Lan","year":"2006","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.bcp.2019.113692_b0560","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1089\/scd.2016.0193","article-title":"Propagating humanized BLT mice for the study of human immunology and immunotherapy","volume":"25","author":"Smith","year":"2016","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.bcp.2019.113692_b0565","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/JVI.03085-13","article-title":"Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing","volume":"88","author":"Frias-Staheli","year":"2014","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.bcp.2019.113692_b0570","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1073\/pnas.1318175111","article-title":"Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.bcp.2019.113692_b0575","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-019-0017-2","article-title":"An injectable bone marrow-like scaffold enhances T cell immunity after hematopoietic stem cell transplantation","volume":"37","author":"Shah","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2019.113692_b0580","first-page":"17","article-title":"In vivo murine-matured human CD3(+) cells as a preclinical model for T cell-based immunotherapies","volume":"6","author":"Haworth","year":"2017","journal-title":"Mol. Therapy"},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0585","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/imr.12128","article-title":"Hematopoietic stem cells for cancer immunotherapy","volume":"257","author":"Gschweng","year":"2014","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2019.113692_b0590","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.it.2018.07.001","article-title":"Humanized mice for the study of immuno-oncology","volume":"39","author":"De La Rochere","year":"2018","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2019.113692_b0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008208","article-title":"Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice","volume":"4","author":"Kitchen","year":"2009","journal-title":"PLoS ONE"},{"issue":"51","key":"10.1016\/j.bcp.2019.113692_b0600","doi-asserted-by":"crossref","first-page":"E1408","DOI":"10.1073\/pnas.1115050108","article-title":"Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells","volume":"108","author":"Vatakis","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.bcp.2019.113692_b0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002649","article-title":"In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells","volume":"8","author":"Kitchen","year":"2012","journal-title":"PLoS Pathog."},{"issue":"29","key":"10.1016\/j.bcp.2019.113692_b0610","doi-asserted-by":"crossref","first-page":"13022","DOI":"10.1073\/pnas.1000475107","article-title":"Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gamma(null) humanized mice","volume":"107","author":"Shultz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.113692_b0615","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fimmu.2018.00746","article-title":"The use of the humanized mouse model in gene therapy and immunotherapy for HIV and cancer","volume":"9","author":"Carrillo","year":"2018","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.bcp.2019.113692_b0620","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-16-1260","article-title":"Humanized mouse xenograft models: narrowing the tumor-microenvironment gap","volume":"76","author":"Morton","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2019.113692_b0625","doi-asserted-by":"crossref","unstructured":"P.A. Horn, H.P. Kiem, Expansion of SCID repopulating cells does not prove expansion of hematopoietic stem cells, Blood 108(2) (2006) 771; author reply 771-2.","DOI":"10.1182\/blood-2006-02-002618"},{"issue":"1","key":"10.1016\/j.bcp.2019.113692_b0630","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.012336799","article-title":"Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD\/SCID mice","volume":"99","author":"Hogan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.bcp.2019.113692_b0635","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.celrep.2013.04.025","article-title":"Revision of the human hematopoietic tree: granulocyte subtypes derive from distinct hematopoietic lineages","volume":"3","author":"G\u00f6rgens","year":"2013","journal-title":"Cell Reports"},{"issue":"8","key":"10.1016\/j.bcp.2019.113692_b0640","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/gt.2010.47","article-title":"Large animal models of hematopoietic stem cell gene therapy","volume":"17","author":"Trobridge","year":"2010","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.bcp.2019.113692_b0645","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.seminhematol.2004.07.002","article-title":"Genetic manipulation of hematopoietic stem cells","volume":"41","author":"Larochelle","year":"2004","journal-title":"Semin. Hematol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219303910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219303910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:14:42Z","timestamp":1757769282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219303910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":129,"alternative-id":["S0006295219303910"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113692","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mouse models in hematopoietic stem cell gene therapy and genome editing","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113692"}}